This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS May 24, 2011
ASCLS eNewsBytes
May 24, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Fate of last smallpox virus stocks divides WHO
Reuters Africa    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health ministers are deeply divided over setting a date to destroy the world's remaining known stocks of live smallpox virus, stored in Russia and the United States. The two powers say that more research is needed into safer vaccines against the deadly disease eradicated more than 30 years ago. They also seek guarantees that all stocks have been destroyed or transferred to their two official repositories due to fears that the virus could be used as a biological weapon. More

Editing scrambled genes in human stem cells may help realize the promise of stem cell-gene therapy
Scicasts    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In principle, genetic engineering is simple, but in practice, replacing a faulty gene with a healthy copy is anything but. Using mutated versions of the lamin A gene as an example to demonstrate the versatility of their virus-based approach, researchers at the Salk Institute for Biological Studies in La Jolla, Calif., successfully edited a diseased gene in patient-specific induced pluripotent stem cells as well as adult stem cells. More

FDA approves test for early diagnosis of Q fever
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration (FDA) approved the first nucleic acid amplification test to diagnose the early stages of Q fever infections in military personnel. The test offers earlier diagnosis of the infectious disease caused by the bacterium Coxiella burnetii. The test was developed by Idaho Technology Inc, based in Salt Lake City. More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit

PARP inhibitor improves outcomes in ovarian cancer
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The experimental agent olaparib (AstraZeneca) might have a role to play in ovarian cancer. Results from a phase 2 trial have shown that it significantly prolonged progression-free survival in patients with platinum-sensitive relapsed serous ovarian cancer. More

Effect of haemoglobin concentration on the clinical outcomes in patients with acute myocardial infarction and the factors related to haemoglobin
7thSpace Interactive    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The impact of haemoglobin concentrations on clinical outcomes is still a controversial issue. To determine the association between haemoglobin concentrations on admission and clinical outcomes and the related factors, this study was performed in a Chinese hospital. FindingsWe conducted a retrospective study on 1394 Chinese patients with acute myocardial infarction. More

New treatment regimen shows clinical benefit in advanced colon cancer
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail
A new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed, say research physicians at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center. The research team found that combining a PARP inhibitor with chemotherapy (temozolomide) offers significant benefit in patients who had no further treatment options. More

Testing blood for circulating tumor cells helps inform clinical decisions about treatments and expensive radiologic scans
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail
Researchers at Georgetown Lombardi Comprehensive Cancer Center say the number of circulating tumor cells in the blood is a "powerful predictor" to help physicians more reliably assess treatment benefit for patients with metastatic breast cancer. More

Specialists in Bone, Growth, Cartilage, Hypertension & Automation

IDS manufactures and markets specialist Immunoassays for diagnostic and research laboratory testing. These include fully automated and manual assays.

Diabetes gene controls 'network' in fat tissue
Heartwire via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An international consortium of scientists has discovered that a particular gene linked with type 2 diabetes and cholesterol, KLF14, appears to be a "master regulator" of a whole network of other genes in adipose tissue. Following up on all of these leads could provide new insights into diabetes and cholesterol regulation. More

Variant in vitamin D receptor gene linked to COPD
Reuters Health via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A variant in the vitamin D receptor gene is linked to chronic obstructive pulmonary disease (COPD), at least in men, according to a new study presented at the American Thoracic Society 2011 International Meeting. More

Peanut-eating donors spark allergic reaction
Reuters via ABC Science    Share    Share on FacebookTwitterShare on LinkedinE-mail
Eating peanuts while watching soccer has led to a discovery: What you eat before you give blood may result in a severe allergic reaction in people who receive that blood. A report in the New England Journal of Medicine concludes that a 6-year-old boy who received a transfusion suffered such a reaction because three of the five donors had eaten peanuts the night before their donation. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes.
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Colby Horton, Vice President of Publishing

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • May 17, 2011
  • May 10, 2011
  • May 3, 2011
  • Dedicated - Bio-Rad - April
  • April 26, 2011
  •  RSS Feed
    Most popular articles